Quinsair

Quinsair Warnings and Precautions

• Bronchospasm: Quinsair can cause bronchospasm; a bronchodilator should be used before each dose, and lung function should be monitored.
• Tendon effects: As with other fluoroquinolones, tendinitis and tendon rupture can occur.
• Peripheral neuropathy: Fluoroquinolones have been associated with peripheral neuropathy, which can be irreversible.
• CNS effects: Dizziness, confusion, and other central nervous system effects can occur.
• QT prolongation: Caution is advised in patients with risk factors for cardiac arrhythmia.
• Hemoptysis: Coughing up blood has been reported, particularly in patients with pre-existing lung damage.

How to Access Quinsair in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Quinsair to India?

Quinsair (levofloxacin) inhalation solution may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified pulmonologist
• The patient's diagnostic reports confirming cystic fibrosis with chronic Pseudomonas aeruginosa pulmonary infection
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Quinsair available in India?

Quinsair (levofloxacin inhalation solution) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Quinsair is not commercially marketed in India.

However, patients in India can legally access Quinsair through the Named Patient Program (NPP) — an import provision that allows patients to receive medicines approved in other countries but not yet marketed in India, under a doctor's prescription and proper regulatory documentation.

Quinsair is approved by the European Medicines Agency (EMA) and Health Canada for chronic Pseudomonas aeruginosa lung infections in cystic fibrosis patients; it is not currently approved by the US FDA. Full transparency is maintained throughout the sourcing process.

Quinsair can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

Sourcing & Delivery of Quinsair

Quinsair is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant logistics to preserve product integrity from dispatch to delivery.

• Storage maintained at 15°C to 30°C throughout transit
• Real-time shipment tracking and delivery updates
• Delivery coordinated directly with the patient, family, or treating hospital

Availability of Quinsair Across Major Cities in India

Named Patient Program supports access to Quinsair for cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections across major cities in India, coordinating documentation, sourcing, and delivery with treating pulmonologists.

Mumbai

Patients in Mumbai can access Quinsair through NPP with support from treating pulmonologists at the city's leading cystic fibrosis centers.

Delhi

In Delhi, NPP coordinates with hospitals and specialty respiratory clinics to facilitate timely access to Quinsair.

Bangalore

Bangalore's pulmonology centers work with NPP to support patients requiring Quinsair.

Chennai

Patients in Chennai can access Quinsair through NPP, with coordination between treating doctors and the program's regulatory and logistics team.

Hyderabad

Hyderabad's respiratory disease centers support diagnosis and access coordination for Quinsair through NPP.

Kolkata

NPP facilitates access to Quinsair for patients in Kolkata under the guidance of treating pulmonologists.

Pune

Patients in Pune can access Quinsair through NPP with prescription-based coordination and delivery support.

Ahmedabad

NPP supports access to Quinsair for patients in Ahmedabad, working directly with treating specialists.

Kochi

Patients in Kochi and across Kerala can access Quinsair through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Quinsair for patients in Chandigarh and the surrounding region.

Jaipur

Patients in Jaipur can access Quinsair through NPP with support from treating pulmonologists.

Lucknow

NPP facilitates access to Quinsair for patients in Lucknow and across Uttar Pradesh.

Bhubaneswar

Patients in Bhubaneswar can access Quinsair through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Quinsair for patients in Guwahati and across the Northeast region.

NPP also supports access for patients in other Indian cities not listed above — contact the team to check availability and timelines for your location.